149 related articles for article (PubMed ID: 34417987)
21. Experimental rationale for treatment of high-risk human melanoma with zinc chloride fixative paste. Increased resistance to tumor challenge in murine melanoma model.
Kalish RS; Wood JA; Siegel DM; Kaye VN; Brooks NA
Dermatol Surg; 1998 Sep; 24(9):1021-5. PubMed ID: 9754091
[TBL] [Abstract][Full Text] [Related]
22. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
23. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
25. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
26. A chemical hemostatic technique for bleeding from malignant wounds.
Kakimoto M; Tokita H; Okamura T; Yoshino K
J Palliat Med; 2010 Jan; 13(1):11-3. PubMed ID: 19827962
[TBL] [Abstract][Full Text] [Related]
27. Successful pre-operative local control of skin exposure by sarcoma using combination of systemic chemotherapy and Mohs' chemosurgery.
Hoshi M; Iwai T; Oebisu N; Nakamura H
World J Surg Oncol; 2020 Feb; 18(1):36. PubMed ID: 32046724
[TBL] [Abstract][Full Text] [Related]
28. [Using Mohs' Paste for Disease Control in a Case of Advanced Mucinous Breast Cancer with Continuous Bleeding from the Primary Tumor Surface].
Fukatsu Y; Fujiwara H; Ono Y; Sugiyama J; Ogura M; Kimizuka K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1837-1838. PubMed ID: 38303224
[TBL] [Abstract][Full Text] [Related]
29. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb.
Sun Q; Chen RR; Shen Y; Mooney DJ; Rajagopalan S; Grossman PM
Pharm Res; 2005 Jul; 22(7):1110-6. PubMed ID: 16028011
[TBL] [Abstract][Full Text] [Related]
30. USE OF CHEMOSURGERY WITH MOHS' PASTE IN ADVANCED CARCINOMA OF THE HEAD.
BUCHWALD H; AUST JB
Am J Surg; 1964 Oct; 108():589-91. PubMed ID: 14211454
[No Abstract] [Full Text] [Related]
31. Naoxintong restores collateral blood flow in a murine model of hindlimb ischemia through PPARδ-dependent mechanism.
Chen L; Zhang L; Fang Z; Li C; Yang Y; You X; Song M; Coffie J; Zhang L; Gao X; Wang H
J Ethnopharmacol; 2018 Dec; 227():121-130. PubMed ID: 30170078
[TBL] [Abstract][Full Text] [Related]
32. [A Case Report of Recurrent Bleeding and Massive Malodorous Effusion Due to Skin Invasion of Advanced Breast Cancer Successfully Treated with Mohs' Paste].
Satoh E; Osanai T; Tomi Y; Nakamura M; Yonekura K; Murakata A; Motoyama K; Tanami H; Sugano N; Sakoma T
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1997-1999. PubMed ID: 30692423
[TBL] [Abstract][Full Text] [Related]
33. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
34. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats.
Zhang M; Gao X; Bai SJ; Ye XM; Zhang J
Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508
[TBL] [Abstract][Full Text] [Related]
35. Examined Generalization of the Mohs' Paste for Genital Symptoms in Gynecological Cancer.
Yanazume S; Dozono H; Ota S; Orita Y; Nakamura T; Togami S; Kamio M; Kobayashi H
J Palliat Med; 2020 Jan; 23(1):10-11. PubMed ID: 31905075
[No Abstract] [Full Text] [Related]
36. Modified method for applying Mohs' paste.
Omigawa C; Hashimoto T; Hanafusa T; Namiki T; Igawa K; Yokozeki H
J Dermatol; 2017 Dec; 44(12):e353-e354. PubMed ID: 28861899
[No Abstract] [Full Text] [Related]
37. Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model.
Horikoshi-Ishihara H; Tobita M; Tajima S; Tanaka R; Oshita T; Tabata Y; Mizuno H
J Vasc Surg; 2016 Dec; 64(6):1825-1834.e1. PubMed ID: 26597457
[TBL] [Abstract][Full Text] [Related]
38. Anti-vascular endothelial growth factor treatment induces blood flow recovery through vascular remodeling in high-fat diet induced diabetic mice.
Xiao L; Yan K; Yang Y; Chen N; Li Y; Deng X; Wang L; Liu Y; Mu L; Li R; Luo M; Ren M; Wu J
Microvasc Res; 2016 May; 105():70-6. PubMed ID: 26808210
[TBL] [Abstract][Full Text] [Related]
39. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
40. The palliative efficacy of modified Mohs paste for controlling canine and feline malignant skin wounds.
Fukuyama Y; Kawarai S; Tezuka T; Kawabata A; Maruo T
Vet Q; 2016 Sep; 36(3):176-82. PubMed ID: 26828294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
